0 items USD 0.00Search
Your search for "delveinsight urea cycle disorders pipeline insight 2018" gave back 45168 results.
The urea cycle disorders are hereditary metabolic disorders caused by a deficiency of one of the enzymes in the urea cycle responsible for removing...
Catalog:
LPI
February 2023
Price: USD 3,660.00
The global Urea Cycle Disorders Treatment Drug market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to...
Catalog:
LPI
May 2023
Price: USD 3,660.00
The global Drugs to Treat Urea Cycle Disorders market size was valued at USD million in 2022 and is forecast to a readjusted size of USD million by...
Catalog:
GIR
November 2023
Price: USD 3,480.00
The urea cycle disorders are hereditary metabolic disorders caused by a deficiency of one of the enzymes in the urea cycle responsible for removing...
Catalog:
MRRPB5
July 2023
Price: USD 4,900.00
The global Drugs to Treat Urea Cycle Disorders market size is expected to reach $ million by 2029, rising at a market growth of % CAGR during the...
Catalog:
GIR
November 2023
Price: USD 4,480.00
The global Drugs to Treat Urea Cycle Disorders market size was valued at US$ million in 2022. With growing demand in downstream market, the Drugs to...
Catalog:
LPI
November 2023
Price: USD 3,660.00
The global Urea Cycle Disorders Treatment Drug market size is expected to reach $ million by 2029, rising at a market growth of % CAGR during the...
Catalog:
GIR
May 2023
Price: USD 4,480.00
The global Urea Cycle Disorders Treatment Drug market size was valued at USD million in 2022 and is forecast to a readjusted size of USD million by...
Catalog:
GIR
May 2023
Price: USD 3,480.00
The global Drugs to Treat Urea Cycle Disorders market is projected to reach US$ million in 2029, increasing from US$ million in 2022, with the CAGR...
Catalog:
MRRPB5
November 2023
Price: USD 2,900.00
The global Urea Cycle Disorders Treatment Drug market was valued at US$ million in 2022 and is anticipated to reach US$ million by 2029, witnessing a...
Catalog:
MRRPB5
May 2023
Price: USD 2,900.00
The urea cycle disorders are hereditary metabolic disorders caused by a deficiency of one of the enzymes in the urea cycle responsible for removing...
Catalog:
MRRPB5
February 2023
Price: USD 2,900.00
Innovation and Clinical Trial Tracking Factbook 2017: An Assessment of the Pharmaceutical Pipeline Summary GBI Research’s latest report, “Innovation...
CBR Pharma Insights
May 2017
Price: USD 2,995.00
Diet therapy is the traditional method of inborn errors of metabolism. Medical food is the specialized food formulated to be consumed under physician...
Catalog:
LPI
February 2023
Price: USD 3,660.00
Ravicti is a medication used in the treatment of certain inborn urea cycle disorders. The medication works by preventing the harmful buildup of...
Catalog:
LPI
March 2023
Price: USD 3,660.00
Glycerol phenylbutyrate (USAN), trade name Ravicti, is a medication used in the treatment of certain inborn urea cycle disorders. The medication...
Catalog:
LPI
March 2023
Price: USD 3,660.00
